2022 IPO
Greenlight Biosciences Stock
Unconstrained Metabolism(R) technology platform to produce sustainable chemicals and fuels
Sign up today and learn more about Greenlight Biosciences Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Greenlight Biosciences Stock
GreenLight Biosciences is a privately-held biotechnology company focused on sustainable production of chemicals and fuels using its Unconstrained Metabolism ® technology platform. This revolutionary technology enables the biological conversion of economical, renewable substrates to valuable products with unprecedented flexibility and control.
Funding History
| August 2013 | $7.0M |
|---|---|
| December 2013 | $1.0M |
| June 2015 | $20.0M |
| July 2015 | $0 |
| September 2017 | $18.0M |
| January 2019 | $50.0M |
Management
Co-Founder, CEO
Andrey Zarur
Co-Founder, Chief Scientific Advisor
James Swartz
EquityZen Recognized As:
